Trademark Overview
On Wednesday, July 1, 2026, a trademark application was filed for LUMARA BIO with the United States Patent and Trademark Office. The USPTO has given the LUMARA BIO trademark a serial number of 99917836. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 1, 2026. This trademark is owned by ITM Isotope Technologies Munich SE. The LUMARA BIO trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Pharmaceutical products; Radiopharmaceuticals; Radiopharmaceutical preparations for diagnostic and therapeutic purposes; Diagnostic preparations and substances for medical purposes; Theranostic preparations for medical purposes; Radioactive pharmaceutical preparations; Radiological contrast agents for medical purposes; Biological preparations for medical purposes; Preparations for oncology; Preparations for nuclear medicine; Radioligands for medical purposes; Radioisotope-containing preparations for medical use; Radioactive isotopes for medical purposes; Medical radionuclides; Intermediates and starting materials for the manufacture of radiopharmaceuticals; Pharmaceutical and radiopharmaceutical active ingredients; Preparations for medical imaging.
Licensing of intellectual property; Licensing of patents, know-how, technologies, and scientific developments; Granting and managing rights to use pharmaceutical and radiopharmaceutical technologies; Licensing of software and data platforms; Management of industrial property rights; Legal advice regarding intellectual property and technology transfer
Manufacture of radiopharmaceuticals; Contract manufacturing of radiopharmaceuticals for third parties; Custom manufacturing of pharmaceutical and radiopharmaceutical products; Production of medical isotopes and radionuclides; Processing of radioactive materials for medical purposes; Irradiation services for medical and pharmaceutical purposes; Manufacture of diagnostic and therapeutic preparations using radioactive isotopes; Technical production services in the field of radiopharmacy and theranostics.
Scientific and technological research in the fields of radiopharmaceuticals, molecular imaging, nuclear medicine, and theranostics; Pharmaceutical research and development; Research and development of diagnostic and therapeutic agents; Radiochemical research services; Clinical research and the conduct of clinical trials; Development and design of medical imaging technologies and analytical methods; Development of software for medical imaging, diagnostics, and treatment planning; Scientific research in the fields of oncology, cardiology, neurology, and rare diseases; Development and manufacture of radiopharmaceuticals on behalf of third parties; Scientific consulting and information services in the field of radiopharmaceuticals and theranostics; Quality control and quality testing of pharmaceutical products; Technological consulting services in the healthcare and pharmaceutical sectors; Software as a Service (SaaS) for medical diagnostics, imaging, treatment planning, and precision medi...
Business consulting in the fields of pharmaceuticals, radiopharmaceuticals, and healthcare; Management and corporate administration for pharmaceutical and medical companies; Marketing, advertising, and sales promotion for pharmaceutical products; Commercial consulting in the fields of radiopharmaceuticals and theranostics; Organization and conduct of trade fairs, conferences, and exhibitions for commercial or promotional purposes; Procurement services for pharmaceutical products; Business brokerage and facilitation of commercial partnerships in the healthcare and pharmaceutical sectors; Distribution services for pharmaceutical and medical products; Import and export services for pharmaceutical and radiopharmaceutical products; Management of commercial supply chains for radiopharmaceuticals and medical isotopes; Commercial exploitation of intellectual property; Marketing of pharmaceutical technologies, patents, know-how, and innovations; Consulting regarding the commercialization of sci...
Medical services; Diagnostic imaging services, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT); Nuclear medicine services; Oncology services; Provision of theranostic treatments; Medical analysis services for diagnostic and therapeutic purposes; Clinical services related to radiopharmaceuticals; Health counseling regarding diagnosis and treatment; Medical services in the field of precision medicine; Therapeutic services using radioligands; Medical services in the field of molecular imaging.
Downloadable software for medical imaging; Software for processing, visualizing, and interpreting diagnostic image data; Software for treatment planning and clinical decision support in oncology and nuclear medicine; Artificial intelligence software for medical diagnostics and imaging; Software for theranostics; Medical image analysis software; Scientific apparatus and instruments for the analysis of radiopharmaceutical data; Downloadable computer programs for medical diagnostics; Electronic databases in the fields of medicine and pharmacy, whether recorded or downloadable; Software for precision medicine; Software for clinical data analysis; Software for managing radiopharmaceutical production and supply chains; Software for the management and analysis of medical and scientific data; Applications for cloud computing and data-driven medical decision support
